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Plant serine proteases have been widely used in food science and technology as well as in medicine. In
this sense, several plant serine proteases have been proposed as potential anti-coagulants and anti-
platelet agents. Previously, we have reported the puriﬁcation and identiﬁcation of a plant serine pro-
tease from Solanum tuberosum leaves. This potato enzyme, named as StSBTc-3, has a molecular weight of
72 kDa and it was characterized as a subtilisin like protease. In this work we determine and characterize
the biochemical and medicinal properties of StSBTc-3. Results obtained show that, like the reported to
other plant serine proteases, StSBTc-3 is able to degrade all chains of human ﬁbrinogen and to produces
ﬁbrin clot lysis in a dose dependent manner. The enzyme efﬁciently hydrolyzes b subunit followed by
partially hydrolyzed a and g subunits of human ﬁbrinogen. Assays performed to determine StSBTc-3
substrate speciﬁcity using oxidized insulin b-chain as substrate, show seven cleavage sites: Asn3-Gln4;
Cys7-Gly8; Glu13-Ala14; Leu15-Tyr16; Tyr16-Leu17; Arg22-Gly23 and Phe25-Tyr26, all of them were
previously reported for other serine proteases with ﬁbrinogenolytic activity. The maximum StSBTc-3
ﬁbrinogenolytic activity was determined at pH 8.0 and at 37 C. Additionally, we demonstrate that StSBTc-
3 is able to inhibit platelet aggregation and is unable to exert cytotoxic activity on human erythrocytes
in vitro at all concentrations assayed. These results suggest that StSBTc-3 could be evaluated as a new
agent to be used in the treatment of thromboembolic disorders such as strokes, pulmonary embolism
and deep vein thrombosis.
© 2016 Elsevier B.V. and Societe Française de Biochimie et Biologie Moleculaire (SFBBM). All rights
reserved.1. Introduction
Proteolytic enzymes (peptidases), usually known as proteases,
are important enzymes which play a signiﬁcant role in various
biochemical mechanisms to maintain metabolic processes of all
organisms [1]. These enzymes, belonging to group 3 (hydrolases)
and subgroup 4 (hydrolases of peptide bonds) (E.C.3.4.), carried out
the hydrolysis of peptide bonds [2,3]. The enzyme subclass of
proteases (EC 3.4) is in turn divided into seven catalytic classeste (IIB), National Council of
ity of Mar del Plata, Mar del
ara).
de Biochimie et Biologie Moleculaccording to their catalytic mechanism. Includes proteases named
as serine, cysteine, aspartic, glutamic, metallo, and threonine, with
a seventh group including peptidases with unidentiﬁed mode of
action [3].
Several proteases, including serine proteases, interfere with
haemostasis and act either as procoagulants or as anticoagulants
[4e6]. According to their action mechanism, thrombolytic agents
are classiﬁed in two types: one is plasminogen activator, such as
tissue type plasminogen activator (t-PA) and urokinase; the other is
the plasmin-like protein, e.g. nattokinase [7] and lumbrokinase [8]
which can directly degrade the ﬁbrin of blood clots, thereby dis-
solving the thrombi rapidly and completely [9]. However, these
enzymes are expensive and patients may suffer from undesirable
side effects such as gastrointestinal bleeding, allergic reaction, andaire (SFBBM). All rights reserved.
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coagulant and thrombolytic reagents from various sources have
been investigated [12].
Plant serine proteases have been widely used in food science
and technology as well as in medicine; however, few plant serine
proteases have found a place in industry [13]. Like their counter-
parts in mammalians, snakes and microorganisms, plant serine
proteases have been proposed as potential anti-coagulants and
anti-platelet agents. In this sense, Siritapetawee et al. [14] have
proposed the potential use of AMP48 (a serine protease from
Artocarpus heterophyllus) as antithrombotic for treatment throm-
boembolic disorders such as strokes, pulmonary embolism and
deep vein thrombosis. Additionally, Fonseca et al. [15] have puriﬁed
and characterized a serine protease with ﬁbrinogenolytic activity
from Euphorbia milii latex. The potential use in medicinal treat-
ment, for example for thrombosis has been suggested for a serine
protease with ﬁbrinogenolytic activity and high stability from
Euphorbia cf. latex named as EuP-82 [1]. Choi et al. [16] have re-
ported the isolation and characterization of a new bifunctional
ﬁbrinolytic serine protease from the green algae Codium fragile
named as Codiase, with thrombolytic, anticoagulant, and anti-
platelet activities. Also, the puriﬁcation of a chymotrypsin-like
ﬁbrinolytic serine protease from Petasites japonicus, has been re-
ported by Kim et al. [17].
Previously, we have reported the puriﬁcation, identiﬁcation and
biochemical characterization of a potato subtilisin-like protease,
named as StSBTc-3 [18]. In this studywe report the ability of StSBTc-3
to degrade human ﬁbrinogen and ﬁbrin in vitro. Additionally, results
obtained demonstrate that this potato protease inhibits platelet ag-
gregation induced by collagen. All these results and the fact that
StSBTc-3 is not cytotoxic to human erythrocytes in vitro, suggest a
potential industrial and therapeutic applications for this protease.
2. Experimental section
2.1. Puriﬁcation and identiﬁcation of StSBTc-3
StSBTc-3 was puriﬁed from intercellular washing ﬂuid of potato
leaves following the method previously described by Fernandez
et al. [18]. Brieﬂy intercellular washing ﬂuid of potato leaves was
obtained by vacuum inﬁltration-centrifugation procedure with
inﬁltration buffer (50mMHCl-Tris (pH 8), 3.5% (w/v) NaCl, 0.1% (v/v)
2-mercaptoethanol and 20 15 mL/15 ml of Tween20). Then, a two-
step chromatographic procedure was employed to purify StSBTc-3
from the ﬂuid. The ﬁrst step of puriﬁcation was an Ion-exchange
chromatography on Mono-Q HR 5/5. The column was equilibrated
in 50 mM sodium acetate (pH 5.2) and eluted with a linear gradient
of 0e500 mM NaCl at 1 mL min1 ﬂow rate. In the second step, the
fractions with speciﬁc activity were concentrated and loaded into a
Superose 12 10/300 size exclusion column (GE Healthcare GE, 17-
5173-01) and eluted with 0.05 M sodium acetate buffer (pH 5.2),
0.3 M NaCl using a ﬂow rate of 0.5 mL min1. The peak at 75 kDa
correspond to StSBTc-3 as reported previously in our lab by Fer-
nandez et al. [18]. StSBTc-3 purity and identity was conﬁrmed
digesting the StSBTc-3 puriﬁed fraction [18] by trypsin and following
by MALDI-TOF-mass spectrometry and subsequently MS/MS anal-
ysis. The resulting spectra was used to search for matching proteins
in the NCBI database (http://www.ncbi.nlm.nih.gov) using the
Mascot search program (http://www.matrixscience.com, Matrix
Science, London, England) and the potato genome database Sol-
genomics (solgenomics.net). As described by Fernndez et al. [18],
MALDI-TOF mass spectra and the sequences of the three tryptic
peptides were obtained. BLASTp and tBLASTn searches against the
potato genome database show 100% of identity with a subtilisin-like
protease from Solanum tuberosum (Transcript and protein ID:PGSC0003DMT400027148 and PGSC0003DMP400018521
respectively).
2.2. Protein concentration determination
Protein concentration was measured by the bicinchoninic acid
method (BCA) [19], using bovine serum albumin for the standard
calibration curve. Brieﬂy, 25 ml of protein solution was mixed with
200 ml of BCA reagent. Themixturewas incubated at 37 C for 30min
and then measured in a microplate Reader ELx800 (BioTek In-
struments) at a wavelength of 540 nm.
2.3. Thrombin clotting time (TCT)
TCT was measured as described by Ignjatovic [20] using an IL
ACL 200 Coagulation Analyzer, Instrumentation Laboratory (USA)
with the TCT assay kit provided by Wiener Labs (Argentina)
following the manufactures instruction. 100 ml of poor-platelet
plasma were incubated with different amounts of StSBTc-3 (from
0 mM to 1 mM), during 2 h at 37 C.
2.4. Determination of StSBTc-3 ﬁbrinogenolytic activity
Fibrinogenolytic activity of StSBTc-3 was tested as described by
Siritapetawee et al. [1] using amodiﬁedmethod of Satake et al. [21].
The reaction mixture was composed of 40 mg of human ﬁbrinogen
and 2 mM of StSBTc-3 in a ﬁnal volume of 100 ml. The reaction
mixture was incubated at 37 C for 2 h. The reaction was stopped by
adding 40 ml of 10% (w/v) trichloroacetic acid (TCA). The digested
peptides were collected by spinning the mixture at 12.000  g for
20 min. The peptide concentration of the supernatant was
measured using the BCA assay (Subsection 2.2). Control assay was
performed using the reaction mixture without enzyme. One unit of
enzyme activity was determined as the amount of enzyme required
to produce an increase in absorbance of 0.01 at 540 nm min1
(37 C).
2.5. Speciﬁcity of ﬁbrinogenolytic activity of StSBTc-3
Subunits of human ﬁbrinogen digested by StSBTc-3 were
analyzed by denaturing sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS) using a method from Rajesh et al. [22] with
slight modiﬁcations. Fresh human plasma from healthy informed
volunteers was used to obtain ﬁbrinogen enriched fraction as
described by Zamora Gonzalez [23]. 40 mg of ﬁbrinogen enriched
fraction were incubated with several amounts of StSBTc-3 (from
0 mM to 3.2 mM) at 37 C during 2 h in a ﬁnal volume of 50 ml. The
reaction was stopped by adding 20 ml of denaturing buffer con-
taining: 1 M urea, 4% (w/v) SDS and 4% 2-Mercaptoethanol and
heated at 95 C during 5 min. All proteins were analyzed by SDS-
PAGE using 15% (p/v) acrylamide gel [24]. Gels were stained with
colloidal Coomasie Brillant Blue G250 [25]. Densitometric analysis
of the SDS-PAGE gel bands were performed using Image J software
[26]. The same methodology was used to perform the time-
dependant assays using 3 mM of StSBTc-3 varying the incubation
times from 0 min to 300 min.
2.6. Speciﬁcity studies of StSBTc-3 proteolytic activity
Oxidized b-chain (5 mg/ml) was incubated with puriﬁed StSBTc-
3 in 0.1 M formic (pH 3.1). After 1, 3 and 24 h at 37 C, the reaction
mixtures were centrifuged and the peptide fragments were sepa-
rated by reverse-phase HPLC using Vydac C18 column, HPLC model
Providence, (SHIMADZU) software LCSolution. The chromatog-
raphy was carried out at room temperature and the column was
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eluted with a linear gradient of acetonitrile (0e80%) in 0.1% TFA at a
ﬂow rate of 1.5 mL min1. Amino acid composition and N-terminal
amino acid sequencing were performed to characterize the isolated
peptides. N-terminal amino acid sequences were determined by
mass spectrometry using a MALDI-TOF-TOF spectrometer, Ultraﬂex
II (Bruker).
2.7. Effects of pH and temperature on ﬁbrinogenolytic activity
The optimal pH was examined varying the pH of the reaction
mixture between 3 and 12. The buffers used were 25 mM sodium
acetate (pH 3e5), 25 mM sodium phosphate (pH 6e7), 25 mM Tris-
HCl (pH 8e9), and 25 mM glycine-NaOH (pH 10e12). Human
ﬁbrinogen substrate was dissolved in the respective buffers. The
optimal pH of StSBTc-3 on ﬁbrinogenolytic activity was assayed
following the method described in Section 2.4. The optimal tem-
perature was determined in the temperature range of 10 Ce95 C
and the ﬁbrinogenolytic activity of StSBTc-3 was assayed following
the method described in 2.4.
The pH stability was determined by pre-incubating StSBTc-3
with respective pH buffers (pH range from 3 to 12) at 37 C for 24 h.
After incubation, the activity of the treated enzyme was deter-
mined by the method described in 2.4 at optymum conditions. The
temperature stability was determined by pre-incubating StSBTc-3
at several temperatures (range from 10 C to 95 C) for 24 h. Then the
activity of treated enzyme was assayed following the method
described in 2.4. at optymum conditions.
All determinations described above were done in triplicate. The
residual activity of the previously treated sample was evaluated
according to the standard condition (Section 2.4) taken as 100%.
2.8. Fibrinolytic activity by microplate clot lysis assay
The decrease in clot turbidity of ﬁbrin polymer by StSBTc-3 was
examined in a 96-well plate in triplicate using an absorbance
microplate Reader ELx800 (BioTek Instruments) at a wavelength of
405 nm. The reaction mixture was prepared as described by Choi
et al. [16] with different amounts from 0.5 mM to 3 mMof StSBTc-3 in
a ﬁnal volume of 100 ml.
2.9. Haemolysis assay
Haemolysis assays were performed as described by Mu~noz et al.
[27]. Fresh human red blood cells (hRBC) were rinsed in PBS and
centrifuged for 10 min at 800  g three times and resuspended in
PBS to a ﬁnal erythrocyte concentration of 4% v/v. The hRBC sus-
pension (100 ml) was added to a 96-well microtiter plate and
incubated with different concentrations 0.5 mM; 1 mM; 2 mM; 3 mM
of StSBTc-3 in PBS buffer. Controls of zero and 100% haemolysis
consisted of hRBC suspended in PBS and 1% Triton X-100, respec-
tively. The suspensions containing hRBC were incubated with
agitation for 1 h at 37 C. The samples were centrifuged at 800  g
for 10 min, and the release of hemoglobin was monitored by
measuring the absorbance of the supernatant at a wavelength of
550 nm in a microplate Reader ELx800 (BioTek Instruments).
2.10. Preparation of washed human platelets
Rich-platelet plasma (RPP) was obtained from fresh human
plasma from healthy informed volunteers according to Marx et al.
[28]. Platelets were separated by centrifugation of RPP at 800  g
for 15min and thenwashed twice with 3.8 mMpH 6.5 Hepes buffer
containing: 137 mM NaCl; 2.7 mM KCl; 1 mM MgCl2; 5.6 mM
glucose; 0.35% bovine serum albumin and 0.4 mM EDTA. Thewashed platelets were resuspended in 3.8 mM pH 7.4 Hepes buffer.
The platelets were counted by Coulter Counter (Coulter Electronics,
USA) and adjusted to a concentration of 3.10 platelets ml1.
2.11. Determination of human platelet aggregation
Platelet aggregation was measured using an Aggregometer 700
(Chrono Log Corp, USA) as previously described by Rho et al. [12].
Brieﬂy, washed platelets (3.10 platelets ml1) were incubated at
37 C in the with or without 0.2 mM of StSBTc-3 for 3 min in the
presence of 1 mM CaCl2, then platelet aggregation was induced by
addition of collagen 5 mg/ml. The resulting aggregation, measured
as the change in light transmission, was recorded for 3 min.
2.12. Statistical analysis
All data are the mean ± standard deviation of at least three
experiments. Statistical signiﬁcance of the results was evaluated
using ANOVA, and Bonferroni or Dunnet t-test as post-test. All P
values were two-sided. All statistical analyses were performed in
GraphPad Prism 6 for Windows Version 6.01, September 21, 2012.
3. Results and discussion
3.1. Fibrin(ogen)olytic activity
In order to elucidate the ability of StSBTc-3 to degrade human
ﬁbrinogen in vitro, assays were performed according to the
described in Subsection 2.5. Several amounts of StSBTc-3 were
incubated for 2 h with human ﬁbrinogen and the degradation
products were analyzed by SDS-PAGE 15% [24]. Human ﬁbrinogen
is composed of two sets of three polypeptide chains termed as a, b
and g subunits. The approximate molecular weights of a, b and g
chains are 63, 56 and 47 kDa respectively. The three chains are
joined by disulﬁde bonds within the N-terminal of E-domain
[29,30]. As illustrated in Fig. 1, all a, b and g chains of ﬁbrinogen
were susceptible to cleavage by StSBTc-3 at all concentrations
assayed in a dose dependent manner. This result is consistent with
previous results reported for plant serine proteases with ﬁbrino-
genolytic activity, which are able to degrade ﬁbrinogen in a dose
dependent manner [14,1]. Differences in the ﬁbrinogenolytic
cleavage speciﬁcity between StSBTc-3 and other plant serine pro-
teases with ﬁbrinogenolytic activity [31,14] were observed in time
dependent assays (Fig. 2) Results showed in Fig. 2 demonstrate that
StSBTc-3 completely hydrolyze b subunit of human ﬁbrinogen and
partially hydrolyze a and g subunit. This result is in disagree with
the data reported by Siritapetawee [14] to a serine protease with
human ﬁbrino(geno)lytic activities from Artocarpus heterophyllus
latex named as AMP48. Authors demonstrate that this protease
digest a chain of ﬁbrinogen ﬁrst and g subunit thereafter [14]. Like
with AMP48 and unlike StSBTc-3, Choi et al. [16] reported the
ability of a serine protease with ﬁbrinogenobrinolytic activity from
the marine green algae Codium fragile, named as Codiase, to target
a-chain of ﬁbrinogen ﬁrst followed by g- and b-chains. Preferences
in the digestion of ﬁbrinogen chains of AMP48; Codiase and StSBTc-
3 make a difference between these plant proteases and proteases
with ﬁbrinogenolytic activity from other sources. a-ﬁbrinogenase
from different sources including snake venom [32], Lampetra
japonica [33], Codium species [34,35], Paecilomyces tenuipes [36],
and Perenniporia fraxinea [37] preferentially hydrolyze a-subunit.
However, the g-chain does not appear to be a second speciﬁc target.
On the other hand, plasmin, a plasma serine protease which plays
an important role in the dissolution of blood clots, completely hy-
drolyzes all subunits of ﬁbrinogen in the same manner [14].
To corroborate the StSBTc-3 in vitro effect on human ﬁbrinogen
Fig. 1. Fibrinogenolytic activity of StSBTc-3 analyzed by dose-dependent. Hydrolysis
patterns of StSBTc-3 on ﬁbrinogen enriched fraction from human plasma are shown on
SDS-PAGE 15%. (A) Fibrinogen enriched fraction of human plasma (40 mg) was incu-
bated with 0 mM (lane 1), 0.2 mM (lane 2), 0.4 mM (lane 3), 0.8 mM (lane 4), 1.6 mM (lane
5) and 3.2 mM (lane 6) of StSBTc-3 for 2 h at 37 C. (B) Densitometric analysis of
ﬁbrinogen chains corresponding to SDS-PAGE 15% bands: a chain (black bars); b chain
(grey bars); g chain (white bars). Graphics and values represent the media of three
independent experiments (Media ± SD). Different letters indicate signiﬁcant differ-
ences with p < 0.001 and p < 0.01 for one-way ANOVA and Tukey tests respectively.
Fig. 2. Fibrinogenolytic activity of StSBTc-3 by time-dependent. Hydrolysis patterns of
StSBTc-3 on ﬁbrinogen enriched fraction from human plasma are shown on SDS-PAGE
15%. (A) Fibrinogen enriched fraction of human plasma (40 mg) was incubated with
StSBTc-3 (3 mM) for 0 min (lane 1); 15 min (lane 2); 30 min (lane 3); 60 min (lane 4);
120 min (lane 5); 240 min (lane 6) and 300 min (lane 7); and 300 min without StSBTc-
3 (lane 8) at 37 C. (B) Densitometric analysis of ﬁbrinogen chains corresponding to
SDS- PAGE 15% bands: a chain (black bars); b chain (grey bars); g chain (white bars).
Graphics and values represent the media of three independent experiments
(Media ± SD).Different letters indicate signiﬁcant differences with p < 0.001 and
p < 0.01 for one-way ANOVA and Tukey tests respectively.
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TCT assay is a coagulation test to evaluate the conversion of
ﬁbrinogen to ﬁbrin. Some factors that made TCT longer are lower
doses of ﬁbrinogen and defects on its quality [20]. As shown in
Table 1, StSBTc-3 increases thrombin time in dose dependent
manner. Data obtained show that StSBTc-3 is able to increase TCT
by more than 40% (1 mM of StSBTc-3). This amounts were in the
same magnitude order than the amounts necessary to produce
human ﬁbrinogen degradation reported for other plant serine
proteases [14,1].
The effect of StSBTc-3 on ﬁbrin clot lysis was examined using an
in vitro ﬁbrin polymer lysis assay [16]. Fibrin clot was ﬁrst generatedTable 1
Effect of StSBTc-3 on thrombin clotting time (TCT). Poor-
platelet plasma was incubated with different concen-
trations 0 mM; 0.08 mM; 0.16 mM; 0.22 mM; 0.30 mM;
0.38 mM and 1 mM of StSBTc-3 for 1 h at 37 C. Values
represent the media of three independent experiments
(Media ± SD).
StSBTc-3 (mM) TCT (s)
0.00 16.2 ± 0.1
0.08 17.5 ± 0.1
0.16 18.4 ± 0.1
0.22 19.4 ± 0.1
0.30 20.1 ± 0.2
0.38 20.5 ± 0.1
1.00 23.3 ± 0.3from ﬁbrinogen by thrombin and clot lysis was then initiated by
addition of StSBTc-3 as described in Section 2.8. Subsequent
dissolution of ﬁbrin polymer was measured with a turbidity assay.
As shown in Fig. 3, StSBTc-3 was able to induce clot lysis comparedFig. 3. Lysis of ﬁbrin clot by StSBTc-3. Fibrin clot lysis was monitored by turbidity assay.
Fibrin clot was prepared as described in experimental section by combining thrombin
and ﬁbrinogen and lysis was initiated by adding different concentrations of StSBTc-3:
1 mM (full line); 2 mM (dot line); 3 mM (segmented line). The decrease in turbidity was
measured at 405 nm. Values represent the media of three independent experiments.
Fig. 4. Hydrolysis of bovine insulin b-chain by StSBTC-3. A. h.p.l.c. of the soluble peptide fragments of the B-chain of insulin produced by StSBTc-3. A sample of 100 ml of the
triﬂuoroacetic acid-soluble degradation products of insulin B-chain was subjected to h.p.l.c. as described in the Experimental section. This is a typical proﬁle of the separated
products. The peptides were eluted with a linear gradient of acetonitrile (0e80%) in 1% (w/v) triﬂuoroacetic acid. The corresponding absorbance peaks from several h.p.l.c. sep-
arations were pooled, and the peptides were identiﬁed in subsequent analyses. B. The arrows indicate the peptide bonds cleaved in oxidized insulin b-chain by StSBTc-3 and other
seine proteases: proteinase K [43]; Helianthus annuus proteinase [41]; Macluralisin [41]; Cucumisin [44]; Partenain [45].
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duce 50% of clot lysis after 15 h of incubation was the same,
approximately, than the amount reported to Codiase [38]. Similar
amounts able to produce ﬁbrin degradation products were re-
ported to AMP48 [14].Fig. 5. Effect of pH on the ﬁbrinogenolytic activity of StSBTc-3. The pH optimum (black
dots) and stability (white dots) of the ﬁbrinogenolytic activity of StSBTc-3 were
determined in the pH range from 3 to 12. The activity was evaluated with the method
described in experimental section (2.4). Values represent the media of three inde-
pendent experiments (Media ± SD).3.2. Digestion of oxidized insulin b-chain by StSBTc-3
The hydrolytic speciﬁcity of StSBTc-3 on oxidized insulin b-chain
was analyzed as a probable explanation of the differences found
between this enzyme and other plant serine proteases in the
speciﬁcity to degrade ﬁbrinogen. The proteinase was incubated
with this substrate and the insulin peptide fragments were sepa-
rated by RP-HPLC and identiﬁed by N-terminal amino acid
sequencing. The same insulin cleavage patternwas obtained after 1,
3 and 24 h incubation, indicating that all possible peptide bondsFig. 6. Effects of temperature on the ﬁbrinogenolytic activity of StSBTc-3. The tem-
perature optimum and stability of ﬁbrinogenolytic activity of StSBTc-3 were deter-
mined in the temperature range from 5 C to 90 C. The activity was evaluated with the
method described in experimental section (2.4). Values represent the media of three
independent experiments (Media ± SD).
Table 2
Effect of StSBTc-3 on human red blood cells. Fresh human red blood cells (hRBC)
were incubated with different concentration of StSBTc-3 dissolved in PBS. Controls
zero and 100% haemolysis consisted of hRBC suspended in PBS and 1% (w/w) TRITON
X-100, respectively. The release of hemoglobin was monitored by measuring the
absorbance of the supernatant at 550 nm. Values represent the media of three in-
dependent experiments (Media ± SD).
Treatment Concentration (mM) Haemolysis of hRBC (%)
PBS buffer e 1.9 ± 0.2
TRITON X-100 buffer e 100
StSBTc-3 0.5 2.1 ± 0.3
StSBTc-3 1 1.8 ± 0.4
StSBTc-3 2 2.2 ± 0.4
StSBTc-3 3 2.1 ± 0.4
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Seven cleavage sites were identiﬁed for the action of the StSBTc-
3: Asn3-Gln4; Cys7-Gly8; Glu13-Ala14; Leu15-Tyr16; Tyr16-Leu17;
Arg22-Gly23 and Phe25-Tyr26 (Fig. 4). As shown in Fig. 4, StSBTc-3
preferentially attacked the peptide bonds after the hydrophobic
amino acid residues Leu, Tyr, Phe, which agrees well with the
speciﬁcity pattern of subtilisin [39,18]. In addition, the bonds be-
tween residues Glu13-Ala14 and Cys7-Gly8 formed by glutamic or
cysteic residues were cleaved. A comparable cleavage pattern was
observed in the course of insulin b-chain hydrolysis with plant
serine proteases from Cucumis melo, Trichosanthes cucumeroides,
Parthenium agentatum, Maclura pomifera (named as Macluralisin).
As reported for a serine protease isolated from Helianthus annuus, a
fungal proteinase A1 from Trichosanthes cucumeroides and human
plasmin [40,41], StSBTc-3 hydrolyzes the amino acid bond between
Arg22-Gly23 (Fig. 4). However, StSBTc-3 is unable to cleave the
peptide bound between Lys29-Ala30 previously reported to human
plasmin [42]. Future assays focused on ﬁnd StSBTc-3 cleavage sites
on human ﬁbrinogen will be performed in order to relate these
results with StSBTc-3 ﬁbrinogen subunits cleavage speciﬁcity.
3.3. Effect of pH and temperature on the ﬁbrinogenolytic activity of
StSBTc-3
Effects of pH and temperature (Figs. 5 and 6) on ﬁbrinolytic
activity and stability of StSBTc-3 were similar with data reported for
other plant; bacterial and green algae serine proteases with ﬁbri-
nogenolytic activity [1,14,16,38,40,46]. StBTc-3 was found to beFig. 7. Antiplatelet activity of StSBTc-3. Platelet aggregation was tested according to
described in experimental section. Washed human platelets were incubated with
0.3 mM of StSBTc-3 (dot line); collagen 5 mg/ml (full line) and collagen 5 mg/ml with
0.2 mM StSBTc-3 (segmented line). Values represent the media of three independent
experiments (Media ± SD).active at pH values ranging from 7 to 11 and temperatures from
20 C to 60 C. The optimal pH for the ﬁbrinogenolytic activity was 8
(Fig. 5) and the optimal temperature was 37 C (Fig. 6). Fibrinoge-
nolytic activity of StSBTc-3 was found to be stable at pH values
ranging from 3 to 12 (manteining 75e100% of it relative activity)
and at temperatures from 10 C to 60 C (manteining 75e100% of it
relative activity). These results are consistent with results previ-
ously reported to StBTc-3 DEVDase activity [47].3.4. In vitro StSBTc-3 haemolytic activity
The cytotoxic activity of StSBTc-3 was tested on human eryth-
rocytes in vitro. StSBTc-3 did not show haemolytic activity against
human erythrocytes at all concentrations assayed (Table 2). This
result is in accordance with the results reported by Majumdar et al.
[38] for a ﬁbrinolytic serine protease from Brevibacillus brevis strain
FF02B with a high therapeutic potential, named as
Brevithrombolase.3.5. Effect of StSBTc-3 on platelet aggregation in vitro
Platelet aggregation is a complex phenomenon that involves
several intracellular biochemical pathways. Platelets readily
aggregate in response to a variety of endogenous signals and
secrete various compounds that cause further aggregation; they
can initiate thrombus formation and precipitate thromboembo-
lism, leading to ischemic diseases [48,49]. Antiplatelet activity has
been reported for several plant proteases and plant extracts
[16,50,51]. In order to elucidate if StSBTc-3 has antiplatelet activity,
platelet aggregation assays mediated by collagen were performed
(Fig. 7). Results obtained here demonstrate that StSBTc-3 inhibits
platelet aggregation induced by collagen at a lower dose (0.2 mM)
than the StSBTc-3 amount necessary to produce both, ﬁbrin clot and
ﬁbrinogen lysis in vitro.4. Conclusions
The results obtained in this work show that StSBTc-3 has ﬁbri-
nogenolytic activity in a dose dependent manner. Additionally, we
demonstrate that contrary to plasmin, a-ﬁbirnogenases and other
plant serin proteases, StSBT3 completely hydrolyzes the b subunit
of human ﬁbrinogen but partially hydrolyzes a and g subunit.
StSBTc-3 concentrations necessary to produce ﬁbrinogen and ﬁbrin
clot lysis were similar to those previously reported for other plant
serine proteases with ﬁbrin(ogen)olytic activity in vitro. StSBTc-3
speciﬁcity assay using oxidized insulin b-chain as substrate shows
seven cleavage sites, all of themwere previously reported for other
serine proteases with ﬁbrinogenolytic activity. Biochemical ana-
lyses determine that ﬁbrinolytic activity of StSBTc-3 is active in a
wider range of pH from 7 to 11 and temperatures from 20 C to 60 C.
This enzyme is stable in a broad range of pH and temperatures. Data
here obtained show that StSBTc-3 is a potential bifunctional agent
for thrombolytic therapy because also inhibits platelet aggregation
induced by collagen. It is interesting that StSBTc-3 seems to inhibit
platelet aggregation at lower dose and at shorter incubation times
than the required for the ﬁbrino(geno)lytic activity. However,
future assays will be necessary to determine StSBTc-3 antiplatelet
mechanism. Additionally, haemolysis assays demonstrate that
StSBTc-3 is not cytotoxic to human erythrocytes at all concentra-
tions assayed. All these results indicate that StSBTc-3 is a serin
protease with high potential industrial and therapeutic applica-
tions in thrombolytic therapies.
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